Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01169272 | Clinical Evaluation Of The SonR Atrial Lead In Paradym RF Device | PHASE3 | COMPLETED | 100 | — | — | Oct 1, 2010 | Jun 1, 2012 | Jun 18, 2014 | 1 | France |
Complication free rate of the SonR lead superior to 90 %
| Arm | Type | Description |
|---|---|---|
| CRT-SonR 9770 | EXPERIMENTAL | Active implantable defibrillator with ability to cardiac resynchronization therapy |
| Name | Type | Description |
|---|---|---|
| CRT-SonR 9770 | DEVICE | Active implantable defibrillator with capacity of cardiac resynchronization therapy |
Inclusion Criteria: * Patient eligible for implantation of a CRT 9770 device accordingly to the relevant currently-approved ACC/AHA/ESC guidelines or any relevant currently approved local guidelines for the implantation or replacement of triple-chamber ICD * Implanted with atrial SonR lead * Signed...